Health
COVID-19 vaccine tested at Emory is safe, generates immune response, early results show – Mirage News
An investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) was generally well tolerated and resulted in production of…
An investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) was generally well tolerated and resulted in production of both binding and neutralizing antibodies in healthy adult volunteers, according to interim results of an ongoing phase 1 trial published today in the New England Journal of Medicine.
The experimental vaccine is being co-developed by researchers at NIAID and at Moderna, Inc. of Cambridge, Massachusetts. Manufactured by Moderna, mRNA-1273 is designe…
-
Noosa News22 hours agoInside the $5.4 million Clayfield home where CEO Greg Josephson was allegedly stabbed to death
-
Business23 hours agoHow you could turn $10k into $100k with ASX shares
-
Business24 hours agoThe best ASX retail shares to buy in FY26
-
Noosa News24 hours agoBy The Sea at Halcyon House: All the Details